Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

SEC Filing · SCHEDULE 13G

LifeMD, Inc.

LFMDNASDAQEQUITYCurrent

SEC Filing

Filed Jul 8, 2026Accepted Jul 8, 2026, 7:45 AM EDTCIK 948320Accession 0001623632-26-000984
Share

Company context

LifeMD® is a leading provider of virtual primary care. LifeMD offers telemedicine, access to laboratory and pharmacy services, and specialized treatment across more than 200 conditions, including primary care, men’s and women’s health, weight management, and hormone therapy. The Company leverages a vertically integrated, proprietary digital care platform, a 50-state affiliated medical group, a state-of-the-art affiliated pharmacy, and a U.S.-based patient care center to increase access to high-quality and affordable care. For more information, please visit LifeMD.com.

Current securities

Recent company filings

  1. S-8 filingSep 25, 2026
  2. Regulation FD DisclosureSep 15, 2026
  3. 4 filingAug 18, 2026
  4. 10-Q filingAug 5, 2026
  5. Results of Operations and Financial Condition · Regulation FD DisclosureAug 5, 2026

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗